BioLargo Inc (BLGO)

[monkeyfrog]

Note 1. Business and Organization

Outlook

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of our business. As reflected in the accompanying consolidated financial statements, we had a net loss of $3,312,728, and cash used in operations of $1,693,661, for the six-months ended June 30, 2016, and at June 30, 2016, we had working capital of $592,391, current assets of $1,003,535, and an accumulated stockholders’ deficit of $87,266,592. The foregoing factors raise substantial doubt about our ability to continue as a going concern. Ultimately, our ability to continue as a going concern is dependent upon our ability to attract significant new sources of capital, attain a reasonable threshold of operating efficiencies and achieve profitable operations by licensing or otherwise commercializing products incorporating our technologies. The consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

http://ih.advfn.com/p.php?pid=nmona&article=72216933